Director (Pharma/Biotech)
Cisema
Over 20 years of experience in regulatory management, clinical expertise, and business development with a strong track record of accelerating market access and driving innovation in the pharmaceutical and biotech sectors.
Previously served as Global Head of Regulatory Affairs at Vita Green, HK, and Regional Head of Regulatory Affairs and Business Development for APAC at PharmaLex Group. Held senior leadership roles in regulatory management at Stada and Merck, overseeing market access and product launches across the EU, US, APAC, and MENA regions. Earlier career experience includes R&D at Eli Lilly, Quality control and management, and local Regulatory Affairs within the chemical and pharmaceutical sectors.
I have technical training in pharmacy, hold an MBA from Macquarie University, Australia, and am based in Hong Kong.
Disclosure information not submitted.
Regulatory Considerations for Gene Therapy in Pediatric Patients
Wednesday, May 14, 2025
08:30 - 09:30 CEST
EMA and FDA Programs to Accelerate Innovation in Treating Unmet Medical Needs
Thursday, May 15, 2025
16:45 - 17:45 CEST
Plenary Session - Disruptive Innovation: Redefining Regulatory Roles
Friday, May 16, 2025
08:30 - 10:00 CEST
Shaping the Future of mRNA Vaccines: A Regulatory Perspective
Friday, May 16, 2025
10:30 - 11:30 CEST